GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Scaled Net Operating Assets

Actelion (Actelion) Scaled Net Operating Assets : 0.41 (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Actelion Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Actelion's operating assets for the quarter that ended in Mar. 2017 was $1,574 Mil. Actelion's operating liabilities for the quarter that ended in Mar. 2017 was $726 Mil. Actelion's Total Assets for the quarter that ended in Dec. 2016 was $2,066 Mil. Therefore, Actelion's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2017 was 0.41.


Actelion Scaled Net Operating Assets Historical Data

The historical data trend for Actelion's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Scaled Net Operating Assets Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.41 0.29 0.33 0.42

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.46 0.45 0.39 0.41

Competitive Comparison of Actelion's Scaled Net Operating Assets

For the Biotechnology subindustry, Actelion's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actelion's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actelion's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Actelion's Scaled Net Operating Assets falls into.



Actelion Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Actelion's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2016 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2016 )
=(Operating Assets (A: Dec. 2016 )-Operating Liabilities (A: Dec. 2016 ))/Total Assets (A: Dec. 2015 )
=(1580.436-770.374)/1924.366
=0.42

where

Operating Assets(A: Dec. 2016 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2066.389 - 485.953
=1580.436

Operating Liabilities(A: Dec. 2016 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=770.374 - 0 - 0
=770.374

Actelion's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2017 )
=(Operating Assets (Q: Mar. 2017 )-Operating Liabilities (Q: Mar. 2017 ))/Total Assets (Q: Dec. 2016 )
=(1573.553-726.38)/2066.389
=0.41

where

Operating Assets(Q: Mar. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2332.191 - 758.638
=1573.553

Operating Liabilities(Q: Mar. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=726.38 - 0 - 0
=726.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actelion Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Actelion's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Actelion (Actelion) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson 08-03-2016

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 01-24-2017

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 02-14-2017

Actelion Still On Growth Track

By reports.droy reports.droy 02-18-2015